These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 34071836

  • 1. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
    Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V.
    Int J Mol Sci; 2021 May 27; 22(11):. PubMed ID: 34071836
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N, Cramer T.
    Drug Resist Updat; 2011 Jun 27; 14(3):191-201. PubMed ID: 21466972
    [Abstract] [Full Text] [Related]

  • 3. HIF-1--a big chapter in the cancer tale.
    Ajduković J.
    Exp Oncol; 2016 Mar 27; 38(1):9-12. PubMed ID: 27031712
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia and cancer cell metabolism.
    Huang D, Li C, Zhang H.
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar 27; 46(3):214-9. PubMed ID: 24389642
    [Abstract] [Full Text] [Related]

  • 5. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications.
    Taneja N, Chauhan A, Kulshreshtha R, Singh S.
    Life Sci; 2024 Sep 01; 352():122890. PubMed ID: 38971364
    [Abstract] [Full Text] [Related]

  • 6. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.
    Kim JY, Lee JY.
    Int J Mol Sci; 2017 Aug 25; 18(9):. PubMed ID: 28841148
    [Abstract] [Full Text] [Related]

  • 7. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
    Halligan DN, Murphy SJ, Taylor CT.
    Semin Immunol; 2016 Oct 25; 28(5):469-477. PubMed ID: 27717536
    [Abstract] [Full Text] [Related]

  • 8. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
    Huang LE.
    Cell Death Differ; 2008 Apr 25; 15(4):672-7. PubMed ID: 18188166
    [Abstract] [Full Text] [Related]

  • 9. Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis.
    Wang X, Zhao D, Xie H, Hu Y.
    Cancer Lett; 2021 Feb 28; 499():49-59. PubMed ID: 33217445
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-inducible factor-1 as a therapeutic target in cancer.
    Tang CM, Yu J.
    J Gastroenterol Hepatol; 2013 Mar 28; 28(3):401-5. PubMed ID: 23173651
    [Abstract] [Full Text] [Related]

  • 11. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M, Bukowska-Strakova K, Kocemba-Pilarczyk KA, Majka M.
    Nutrients; 2018 Jun 28; 10(7):. PubMed ID: 29958416
    [Abstract] [Full Text] [Related]

  • 12. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
    Wang KS, Ma J, Mi C, Li J, Lee JJ, Jin X.
    Oncol Rep; 2016 Apr 28; 35(4):2045-52. PubMed ID: 26781327
    [Abstract] [Full Text] [Related]

  • 13. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T, Kitajima Y, Miyake S, Yanagihara K, Hara H, Nishijima-Matsunobu A, Baba K, Shida M, Wakiyama K, Nakamura J, Noshiro H.
    PLoS One; 2015 Apr 28; 10(9):e0137257. PubMed ID: 26339797
    [Abstract] [Full Text] [Related]

  • 14. Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells.
    Park MK, Ji J, Haam K, Han TH, Lim S, Kang MJ, Lim SS, Ban HS.
    Biomed Pharmacother; 2021 Jan 28; 133():111082. PubMed ID: 33378978
    [Abstract] [Full Text] [Related]

  • 15. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E, Cairns RA, Chaudary N, Vellanki RN, Kalliomaki T, Moriyama EH, Mujcic H, Wilson BC, Wouters BG, Hill R, Milosevic M.
    BMC Cancer; 2017 Jun 15; 17(1):418. PubMed ID: 28619042
    [Abstract] [Full Text] [Related]

  • 16. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A, Boeckx C, Vermorken JB, Van den Weyngaert D, Peeters M, Lardon F.
    Curr Pharm Des; 2013 Jun 15; 19(5):907-17. PubMed ID: 22973959
    [Abstract] [Full Text] [Related]

  • 17. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y, Liu J, Huang H.
    J Cell Biochem; 2013 Mar 15; 114(3):498-509. PubMed ID: 22961911
    [Abstract] [Full Text] [Related]

  • 18. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia.
    Lee GY, Chun YS, Shin HW, Park JW.
    Oncotarget; 2016 Aug 30; 7(35):57442-57451. PubMed ID: 27447861
    [Abstract] [Full Text] [Related]

  • 19. A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration.
    Ban HS, Xu X, Jang K, Kim I, Kim BK, Lee K, Won M.
    PLoS One; 2016 Aug 30; 11(9):e0162568. PubMed ID: 27611801
    [Abstract] [Full Text] [Related]

  • 20. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, Yew DT, Vanacker JM, Chan FL.
    J Pathol; 2014 May 30; 233(1):61-73. PubMed ID: 24425001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.